 |
Stomach Cancer News - Special Coverage - Cancer News RSS Feeds from Brightsurf Science News
Special Coverage - Cancer :: Stomach Cancer
Stomach Cancer News Stories, Current Stomach Cancer News Events, Discoveries and Articleshttp://www.brightsurf.com/rss.news.xml?search=Stomach_Cancer
Stomach Cancer News Stories
Current Stomach Cancer News Events, Discoveries and Articles
OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy
New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer. (2008-05-30)
Early treatment of stomach infection may prevent cancer
Based on research using a new mouse model of gastritis and stomach cancer, researchers from the Massachusetts Institute of Technology (MIT) say that prompt treatment of Helicobacter pylori (H. pylori) infections reverses damage to the lining of the stomach that can lead to cancer. (2008-05-01)
Stomach stem cell discovery could bring cancer insights
Scientists have identified and described stem cells specific to several tissues and organs of the body - key master cells that give rise to the specialized cell types characteristic of that organ. (2007-10-04)
Stomach cancer rate set to fall further 25 percent over next decade
New cases of stomach cancer are set to plummet a further 25 per cent in the West over the next decade, indicates research published ahead of print in the journal Gut. (2007-08-14)
Researchers identify cell pathway in colon cancer
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism. (2007-02-21)
Researchers identify cell pathway in colon cancer
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism. (2007-02-20)
Researcher hits bulls-eye for antibiotic target
A Purdue University researcher has opened the door for possible antibiotic treatments for a variety of diseases by determining the structure of a protein that controls the starvation response of E. coli. (2006-08-23)
Basic work on E. coli identifies two new keys to regulation of bacterial gene expression
The cellular process of transcription, in which the enzyme RNA polymerase constructs chains of RNA from information contained in DNA, depends upon previously underappreciated sections of both the DNA promoter region and RNA polymerase, according to work done with the bacterium E. coli. (2006-06-19)
Mayo Clinic studies find association between acid reflux and esophageal cancer
Two new Mayo Clinic studies draw attention to the risk factors and possible genetic basis for Barrett's esophagus and esophageal cancer (adenocarcinoma). (2006-05-24)
Sunitinib prolongs survival in GIST patients after imatinib mesylate failure
Updated results from a Phase III trial presented at the 13th European Cancer Conference (ECCO) show that sunitinib (SU11248) prolongs both progression-free and overall survival in patients with progressive metastatic and/or unresectable GIST whose disease has failed to respond to the standard therapy-imatinib mesylate. (2005-11-04)
Current Stomach Cancer News Events, Discoveries and Articles
OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy
New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer. (2008-05-30)
Early treatment of stomach infection may prevent cancer
Based on research using a new mouse model of gastritis and stomach cancer, researchers from the Massachusetts Institute of Technology (MIT) say that prompt treatment of Helicobacter pylori (H. pylori) infections reverses damage to the lining of the stomach that can lead to cancer. (2008-05-01)
Stomach stem cell discovery could bring cancer insights
Scientists have identified and described stem cells specific to several tissues and organs of the body - key master cells that give rise to the specialized cell types characteristic of that organ. (2007-10-04)
Stomach cancer rate set to fall further 25 percent over next decade
New cases of stomach cancer are set to plummet a further 25 per cent in the West over the next decade, indicates research published ahead of print in the journal Gut. (2007-08-14)
Researchers identify cell pathway in colon cancer
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism. (2007-02-21)
Researchers identify cell pathway in colon cancer
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism. (2007-02-20)
Researcher hits bulls-eye for antibiotic target
A Purdue University researcher has opened the door for possible antibiotic treatments for a variety of diseases by determining the structure of a protein that controls the starvation response of E. coli. (2006-08-23)
Basic work on E. coli identifies two new keys to regulation of bacterial gene expression
The cellular process of transcription, in which the enzyme RNA polymerase constructs chains of RNA from information contained in DNA, depends upon previously underappreciated sections of both the DNA promoter region and RNA polymerase, according to work done with the bacterium E. coli. (2006-06-19)
Mayo Clinic studies find association between acid reflux and esophageal cancer
Two new Mayo Clinic studies draw attention to the risk factors and possible genetic basis for Barrett's esophagus and esophageal cancer (adenocarcinoma). (2006-05-24)
Sunitinib prolongs survival in GIST patients after imatinib mesylate failure
Updated results from a Phase III trial presented at the 13th European Cancer Conference (ECCO) show that sunitinib (SU11248) prolongs both progression-free and overall survival in patients with progressive metastatic and/or unresectable GIST whose disease has failed to respond to the standard therapy-imatinib mesylate. (2005-11-04)
| © 2008 BrightSurf.com |